MetLife Investment Management, LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 112 filers reported holding MIRATI THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.7%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$39,422
+20.8%
905
+0.2%
0.00%
Q2 2023$32,625
-5.0%
903
-2.3%
0.00%
Q1 2023$34,354
-17.8%
924
+0.2%
0.00%
Q4 2022$41,776
-32.4%
922
+4.2%
0.00%
-100.0%
Q3 2022$61,808
+1.6%
885
-2.3%
0.00%
Q2 2022$60,820
-69.1%
906
-62.2%
0.00%
-100.0%
Q1 2022$197,081
-92.8%
2,397
-85.0%
0.00%
-96.2%
Q1 2021$2,734,462
-26.8%
15,963
-6.2%
0.03%
-31.6%
Q4 2020$3,736,296
+43.9%
17,011
+8.8%
0.04%
+35.7%
Q3 2020$2,595,694
+40.5%
15,632
-3.4%
0.03%
+33.3%
Q2 2020$1,846,814
+89.8%
16,176
+27.8%
0.02%
+50.0%
Q1 2020$972,790
-37.0%
12,655
+5.5%
0.01%
-12.5%
Q4 2019$1,545,031
+65.4%
11,9900.0%0.02%
+45.5%
Q3 2019$934,141
-19.3%
11,990
+6.7%
0.01%
-15.4%
Q2 2019$1,157,614
+64.9%
11,239
+17.4%
0.01%
+62.5%
Q1 2019$701,994
+92.6%
9,577
+11.4%
0.01%
+60.0%
Q4 2018$364,557
-9.9%
8,5940.0%0.01%
+25.0%
Q3 2018$404,777
-4.5%
8,5940.0%0.00%
-20.0%
Q2 2018$424,0008,5940.01%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders